Balance Sheet
Cash Flow Statement
Change in Account PayablesChange in Inventory
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed (MYNZ) Capital Expenditures (2022 - 2023)

Historic Capital Expenditures for Mainz Biomed (MYNZ) over the last 2 years, with Q4 2023 value amounting to $2.2 million.

  • Mainz Biomed's Capital Expenditures rose 7171.03% to $2.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year increase of 8206.1%. This contributed to the annual value of $104949.0 for FY2024, which is 9124.58% down from last year.
  • As of Q4 2023, Mainz Biomed's Capital Expenditures stood at $2.2 million, which was up 7171.03% from -$12478.0 recorded in Q3 2023.
  • In the past 5 years, Mainz Biomed's Capital Expenditures ranged from a high of $2.2 million in Q4 2023 and a low of -$900930.0 during Q1 2023